Ouchi, K., Shinozaki, E., Shimada, K., Takahashi, S., Sugimoto, K., Matsumoto, H., Amagai, K., Suto, T., Sakamoto, Y., Okita, A., Otsuka, K., Akazawa, N., Isobe, T., Fukuda, K., Shimodaira, H., Shindo, Y., Yaegashi, M., Kawakami, H., Ishioka, C. (2026). T-CORE2401 trial: A randomized phase II trial of mFOLFOX6 plus cetuximab versus mFOLFOX6 plus bevacizumab as first-line treatment for right-sided,
                    <i>RAS</i>
                    /
                    <i>BRAF</i>
                    wild-type, low-methylated metastatic colon cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.tps280